Objective
MMbio will bridge the classically separate disciplines of Chemistry and Biology by assembling leading experts from academia and non-academic partners (industry, technology transfer & science communication) to bring about systems designed to interfere therapeutically with gene expression in living cells. Expertise in nucleic acid synthesis, its molecular recognition and chemical reactivity is combined with drug delivery, cellular biology and experimental medicine. This project represents a concerted effort to make use of a basic and quantitative understanding of chemical interactions to develop and deliver oligonucleotide molecules of utility for therapy. Our chemical biology approach to this field is ambitious in its breadth and represents a unqiues opportunity to educate young scientists across sectorial and disciplinary barriers. Training will naturally encompass a wide range of skills, requiring a joint effort of chemists and biologists to introduce young researchers in a structured way to and array of research methodologies that no single research grouping could provide. The incorporation of early-stage and later stag ebiotechnology enterprises ensures that commercialisation of methodologies as well as the drug development process is covered in this ITN. We hope that MMBio will train scientists able to understand both the biological problem and the chemistry that holds the possible solution and develop original experimental approaches to stimulate European academic and commercial success in this area.
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- medical and health sciencesmedical biotechnologygenetic engineeringgene therapy
- social scienceseconomics and businessbusiness and managemententrepreneurship
- engineering and technologyother engineering and technologiesmicrotechnologymolecular engineering
Programme(s)
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
CB2 1TN Cambridge
United Kingdom
See on map
Participants (12)
60323 Frankfurt Am Main
See on map
17177 Stockholm
See on map
104 22 Stockholm
See on map
9000 Gent
See on map
35122 Padova
See on map
S10 2TN Sheffield
See on map
Participation ended
501 15 BORAS
See on map
3012 Bern
See on map
20014 Turku
See on map
CB21 6GH Cambridge
See on map
151 85 Sodertaelje
See on map
501 15 Boras
See on map
Partners (6)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
182 60 DJURSHOLM
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
35121 Padova
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
CB4 3QU Cambridge
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
3012 Bern
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
CB3 0GT CAMBRIDGE
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
EC3N 2AE LONDON
See on map